Kosmix
One sec... we're building your guide for
Eculizumab
Eculizumab
Overview
Before Use
Proper Use
Side Effects
Reference
News & Blogs
Patient Experiences
More
Video
Tools
Main ›
Before Use ›
Proper Use ›
Side Effects ›
Reference ›
News & Blogs ›
Patient Experiences ›
Video ›
Tools ›
Related in the Kosmos
?
Orphan drugs
Bevacizumab
Orphan drug
Monoclonal antibodies
(186)
Abatacept
Adalimumab
Afelimomab
Aflibercept
Afutuzumab
Afutuzumab
Alacizumab pegol
Alemtuzumab
Apolizumab
Aselizumab
Atlizumab
Bivatuzumab mertansine
Cantuzumab mertansine
Cedelizumab
Certolizumab pegol
Citatuzumab bogatox
Clenoliximab
Daclizumab
Dorlixizumab
Erlizumab
Etaracizumab
Faralimomab
Farletuzumab
Felvizumab
Fontolizumab
Gantenerumab
Gomiliximab
Humanized
Inotuzumab ozogamicin
Lebrilizumab
Maslimomab
Mepolizumab
Milatuzumab
Nerelimomab
Ocrelizumab
Omalizumab
Oportuzumab monatox
Pascolizumab
Pexelizumab
Reslizumab
Rovelizumab
Ruplizumab
Sibrotuzumab
Siplizumab
Solanezumab
Tacatuzumab tetraxetan
Tadocizumab
Talizumab
Tefibazumab
Teneliximab
Teplizumab
Tigatuzumab
Toralizumab
Tucotuzumab celmoleukin
Urtoxazumab
Vapaliximab
Vedolizumab
Vepalimomab
Visilizumab
3F8
Abagovomab
Abciximab
Abzyme
Adecatumumab
Altumomab
Anatumomab mafenatox
Atorolimumab
Bapineuzumab
Basiliximab
Bavituximab
Bectumomab
Belatacept
Belimumab
Bertilimumab
Besilesomab
Bevacizumab
Biciromab
Bispecific monoclonal antibody
Blinatumomab
Brentuximab vedotin
Cambridge Antibody Technology
Canakinumab
Catumaxomab
Cetuximab
Cixutumumab
Conatumumab
Dacetuzumab
Denosumab
Detumomab
Ecromeximab
Edobacomab
Edrecolomab
Efalizumab
Efungumab
Elotuzumab
Elsilimomab
Epratuzumab
Ertumaxomab
Etanercept
Exbivirumab
Figitumumab
Foravirumab
Fresolimumab
Galiximab
Gavilimomab
Gemtuzumab ozogamicin
Golimumab
HuMax
Ibalizumab
Ibritumomab tiuxetan
Igovomab
Imciromab
Indium (111In) capromab pendetide
Indium (111In) satumomab pendetide
Infliximab
Inolimomab
Ipilimumab
Iratumumab
Keliximab
Labetuzumab
Lemalesomab
Lerdelimumab
Lexatumumab
Libivirumab
Lintuzumab
List of monoclonal antibodies
Lucatumumab
Lumiliximab
Mapatumumab
Matuzumab
Metelimumab
Minretumomab
Mitumomab
Morolimumab
Motavizumab
Nacolomab tafenatox
Naptumomab estafenatox
Natalizumab
Nebacumab
Necitumumab
Nimotuzumab
Nomenclature of monoclonal antibodies
Odulimomab
Ofatumumab
Oregovomab
Otelixizumab
PRO 140
Pagibaximab
Palivizumab
Panitumumab
Panobacumab
Pemtumomab
Personalized medicine
Pertuzumab
Priliximab
Pritumumab
Rafivirumab
Ramucirumab
Ranibizumab
Raxibacumab
Regavirumab
Rilonacept
Rituximab
Robatumumab
Sevirumab
Siltuximab
Stamulumab
TGN1412
Tanezumab
Taplitumomab paptox
Technetium (99mTc) arcitumomab
Technetium (99mTc) fanolesomab
Technetium (99mTc) nofetumomab merpentan
Technetium (99mTc) pintumomab
Technetium (99mTc) sulesomab
Technetium (99mTc) votumumab
Telimomab aritox
Tenatumomab
Trastuzumab
Tremelimumab
Tuvirumab
Ustekinumab
Veltuzumab
Volociximab
Zalutumumab
Zanolimumab
Zolimomab aritox
more...
Immunosuppressants
(32)
Abetimus
Alefacept
Abatacept
Adalimumab
Afelimomab
Afelimomab
Anakinra
Anti-thymocyte globulin
Atlizumab
Azathioprine
Basiliximab
Certolizumab pegol
Ciclosporin
Daclizumab
Efalizumab
Etanercept
Everolimus
Gusperimus
Infliximab
Leflunomide
Lenalidomide
Mepolizumab
Methotrexate
Muromonab-CD3
Mycophenolate mofetil
Mycophenolic acid
Natalizumab
ReciGen
Rilonacept
Sirolimus
Tacrolimus
Thalidomide
Ustekinumab
more...
Immunology
Immunosuppressive
CD59
Monoclonal antibody
Humanized
Cancer treatments
Sibrotuzumab
Tucotuzumab celmoleukin
Tacatuzumab tetraxetan
Bivatuzumab mertansine
Cantuzumab mertansine
Etaracizumab
Inotuzumab ozogamicin
Hematology
Paroxysmal nocturnal hemoglobinuria
Hemolysis
Red blood cells
Myelodysplastic syndromes
Blood clots
Pharmacology
Drugs
Open label
New drug application
Certolizumab pegol
Diseases and disorders
Atypical hemolytic uremic syndrome
Hemoglobinuria
Meningococcal infection
Meningitis
Paroxysmal nocturnal hemoglobinuria
Myelodysplastic syndromes
Blood clots
Immune system
(29)
Complement protein
Rontalizumab
Antigen
Monoclonal antibody
Immunosuppressants
Immunosuppressants
Tocilizumab
Vedolizumab
Talizumab
Erlizumab
Toralizumab
Ruplizumab
Pascolizumab
Siplizumab
Rovelizumab
Fontolizumab
Pexelizumab
Visilizumab
Reslizumab
Teplizumab
Ocrelizumab
Mepolizumab
Humanized
Immunosuppressive
Efalizumab
Epratuzumab
Ibalizumab
Natalizumab
TGN1412
CD59
more...
See also
(20)
ATC code L04
Anti-lymphocyte globulin
Chemical substances
Purine synthesis inhibitor
Anatomical Therapeutic Chemical Classification System
Anatomical Therapeutic Chemical Classification System
Alexion
National Party of Honduras
TNF inhibitor
Irving Adler
Aplastic anemia
Blood cells
CTLA-4
Severe headache
Akershus University Hospital
C5b
The New England Journal of Medicine
Intravascular
Br. J. Haematol.
Anticoagulant
Nondestructive testing
more...
more categories...
Health Providers & Organizations
›
Vitals.com
